June is when spring makes way for summer’s guilty pleasures, and for Health Law Scan these included reading highly anticipated decisions by the US Supreme Court and state legislation signed into law. In the last month, Health Law Scan analyzed Supreme Court opinions on notice and comment rulemaking for Medicare policy changes with substantive legal effect, the exemption of proprietary information from disclosure under the Freedom of Information Act, and the “zombification” of Auer deference. We also evaluated enacted Texas legislation considered by many to be among the strongest drug price transparency laws in the nation. CMS changes to the Recovery Audit Program and draft guidance on hospital co-location arrangements rounded out the must-reads in our beach bag, along with the top five telehealth legal issues for this summer. So if you happened to miss a blog post or two while co-locating at the beach or pool, it’s not a worry because we’ve gathered them here.
- The Zombification of Auer: Supreme Court Cabins Agency Deference in Kisor v. Wilkie
- Keeping Information Private: Supreme Court Interprets FOIA Disclosure Requirements
- Latest Proposed Tariffs Include Medical Devices and Other FDA-Regulated Products
- CMS Draft Co-Location Guidance Presents Opportunity for Providers to Raise Compliance Concerns
- New Texas Law Mandating Drug Price Transparency Considered Among Strongest in Nation
- Employers in Dallas and San Antonio: Prepare to Comply with Paid Sick Leave Ordinances
- Tele-Tuesday: Top Five Telehealth Legal Issues for Summer 2019
- CMS Administrator Touts Changes to RAC Program
- US Supreme Court: CMS Must Follow Notice and Comment Rulemaking for Medicare Policy Changes with Substantive Legal Effect